{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:40:35Z","timestamp":1788478835982,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007132","name":"Otsuka Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013327","name":"H. Lundbeck A\/S","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.schres.2020.03.009","type":"journal-article","created":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T07:41:11Z","timestamp":1586245271000},"page":"240-247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Duration of active psychosis during early phases of the illness and functional outcome: The PAFIP 10-year follow-up study"],"prefix":"10.1016","volume":"220","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7620-9703","authenticated-orcid":false,"given":"Guillermo","family":"Pardo-de-Santayana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5478-3376","authenticated-orcid":false,"given":"Javier","family":"V\u00e1zquez-Bourgon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"G\u00f3mez-Revuelta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Ayesa-Arriola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Ortiz-Garcia de la Foz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicto","family":"Crespo-Facorro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Pelayo-Ter\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.schres.2020.03.009_bb0005","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/jcp.0b013e3180d0a6d4","article-title":"Early use of clozapine for poorly responding first-episode psychosis","volume":"27","author":"Agid","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1\u20133","key":"10.1016\/j.schres.2020.03.009_bb5000","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.schres.2012.05.007","article-title":"Risk factors for relapse following treatment for first episode psychosis: a systematic review and meta-analysis of longitudinal studies","volume":"139","author":"Alvarez-Jimenez","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2020.03.009_bb0015","series-title":"The Scale for the Assessment of Negative Symptoms (SANS) Iowa City","author":"Andreasen","year":"1983"},{"key":"10.1016\/j.schres.2020.03.009_bb0020","series-title":"Scale for the Assessment of Positive Symptons:(SAPS)","author":"Andreasen","year":"1984"},{"issue":"3","key":"10.1016\/j.schres.2020.03.009_bb0025","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","article-title":"Remission in schizophrenia: proposed criteria and rationale for consensus","volume":"162","author":"Andreasen","year":"2005","journal-title":"Am. J. Psychiatr."},{"issue":"3","key":"10.1016\/j.schres.2020.03.009_bb7000","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.psychres.2014.11.054","article-title":"10 year course of IQ in first-episode psychosis: Relationship between duration of psychosis and long-term intellectual trajectories","volume":"225","author":"Barder","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2020.03.009_bb0035","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.schres.2017.08.032","article-title":"Targeting recovery in first episode psychosis: the importance of neurocognition and premorbid adjustment in a 3-year longitudinal study","volume":"195","author":"Calvo","year":"2018","journal-title":"Schizophr. Res."},{"issue":"8","key":"10.1016\/j.schres.2020.03.009_bb0040","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jpsychires.2012.05.001","article-title":"Predicting relapse after a first episode of non-affective psychosis: a three-year follow-up study","volume":"46","author":"Caseiro","year":"2012","journal-title":"J. Psychiatr. Res."},{"issue":"10","key":"10.1016\/j.schres.2020.03.009_bb0045","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.4088\/JCP.v67n1004","article-title":"A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis","volume":"67","author":"Crespo-Facorro","year":"2006","journal-title":"The Journal of clinical psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2020.03.009_bb9000","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s11920-008-0034-1","article-title":"Treatment of the first episode of schizophrenia: an update on pharmacologic and psychological interventions","volume":"10","author":"Crespo-Facorro","year":"2008","journal-title":"Curr. Psychiatry Rep."},{"issue":"2","key":"10.1016\/j.schres.2020.03.009_bb0050","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/JCP.0b013e3182825c1e","article-title":"Aripiprazole, ziprasidone, and quetiapine in the treatment of first-episode nonaffective psychosis: results of a 6-week, randomized, flexible-dose, open-label comparison","volume":"33","author":"Crespo-Facorro","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.schres.2020.03.009_bb0055","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-244X-13-50","article-title":"The nature of relapse in schizophrenia","volume":"13","author":"Emsley","year":"2013","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2020.03.009_bb0060","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/JCP.0b013e31827bfcc1","article-title":"Comparison of treatment response in second-episode versus first-episode schizophrenia","volume":"33","author":"Emsley","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2020.03.009_bb0065","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders","author":"First","year":"1997"},{"issue":"4","key":"10.1016\/j.schres.2020.03.009_bb4000","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1176\/appi.ps.201400558","article-title":"Early predictors of ten-year course in first-episode psychosis","volume":"67","author":"Friis","year":"2016","journal-title":"Psychiatr. Serv."},{"issue":"6","key":"10.1016\/j.schres.2020.03.009_bb0075","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1017\/S0033291709991267","article-title":"Prognostic value of cognitive functioning for global functional recovery in first-episode schizophrenia","volume":"40","author":"Gonz\u00e1lez-Blanch","year":"2010","journal-title":"Psychol. Med."},{"issue":"2","key":"10.1016\/j.schres.2020.03.009_bb0080","first-page":"627","article-title":"Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation","volume":"4","author":"Hajian-Tilaki","year":"2013","journal-title":"Caspian journal of internal medicine"},{"issue":"5","key":"10.1016\/j.schres.2020.03.009_bb0085","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S2215-0366(18)30090-7","article-title":"Long-term effects of discontinuation from antipsychotic maintenance following first-episode schizophrenia and related disorders: a 10 year follow-up of a randomised, double-blind trial","volume":"5","author":"Hui","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2020.03.009_bb8000","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/schbul\/sbs130","article-title":"A systematic review and meta-analysis of recovery in schizophrenia","volume":"39","author":"J\u00e4\u00e4skel\u00e4inen","year":"2013","journal-title":"Schizophr. Bull."},{"issue":"8","key":"10.1016\/j.schres.2020.03.009_bb0095","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/0004867417747401","article-title":"Pathways to functional outcomes following a first episode of psychosis: the roles of premorbid adjustment, verbal memory and symptom remission","volume":"52","author":"Jordan","year":"2018","journal-title":"Australian & New Zealand Journal of Psychiatry"},{"issue":"11","key":"10.1016\/j.schres.2020.03.009_bb0100","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0006-3223(01)01303-8","article-title":"The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches","volume":"50","author":"Lieberman","year":"2001","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2020.03.009_bb0105","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/eip.12217","article-title":"Duration of active psychosis and first-episode psychosis negative symptoms","volume":"11","author":"Lyne","year":"2017","journal-title":"Early intervention in psychiatry"},{"issue":"9","key":"10.1016\/j.schres.2020.03.009_bb0110","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/archpsyc.62.9.975","article-title":"Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review","volume":"62","author":"Marshall","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2020.03.009_bb0115","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1139\/jpn.0212","article-title":"Assessment of premorbid function in first-episode schizophrenia: modifications to the Premorbid Adjustment Scale","volume":"27","author":"van Mastrigt","year":"2002","journal-title":"J. Psychiatry Neurosci."},{"issue":"4","key":"10.1016\/j.schres.2020.03.009_bb0120","doi-asserted-by":"crossref","first-page":"492","DOI":"10.4088\/JCP.14m09540","article-title":"Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study","volume":"77","author":"Mayoral-van","year":"2016","journal-title":"The Journal of clinical psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2020.03.009_bb0125","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/schbul\/sbl032","article-title":"Schizophrenia in translation: is active psychosis neurotoxic?","volume":"32","author":"McGlashan","year":"2006","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.schres.2020.03.009_bb0130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/schbul\/22.2.201","article-title":"Early detection and intervention with schizophrenia: rationale","volume":"22","author":"McGlashan","year":"1996","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2020.03.009_bb0135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.neulet.2016.10.003","article-title":"Duration of untreated illness as a key to early intervention in schizophrenia: a review","volume":"669","author":"Murru","year":"2018","journal-title":"Neurosci. Lett."},{"issue":"10","key":"10.1016\/j.schres.2020.03.009_bb0140","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1177\/070674371405901004","article-title":"Are the effects of duration of untreated psychosis socially mediated?","volume":"59","author":"Norman","year":"2014","journal-title":"Can. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2020.03.009_bb0145","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/eip.12542","article-title":"Impact of tobacco, alcohol and cannabis use on treatment outcomes among patients experiencing first episode psychosis: data from the national RAISE-ETP study","volume":"13","author":"Oluwoye","year":"2019","journal-title":"Early intervention in psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2020.03.009_bb0150","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol. Rep."},{"key":"10.1016\/j.schres.2020.03.009_bb0155","doi-asserted-by":"crossref","unstructured":"Pelayo-Ter\u00e1n, J. M., P\u00e9rez-Iglesias, R., Ram\u00edrez-Bonilla, M., Gonz\u00e1lez-Blanch, C., Mart\u00ednez-Garc\u00eda, O., Pardo-Garc\u00eda, G., \u2026 & V\u00e1zquez-Barquero, J. L. (2008). Epidemiological factors associated with treated incidence of first-episode non-affective psychosis in Cantabria: insights from the Clinical Programme on Early Phases of Psychosis. Early intervention in psychiatry, 2(3), 178\u2013187.","DOI":"10.1111\/j.1751-7893.2008.00074.x"},{"issue":"4","key":"10.1016\/j.schres.2020.03.009_bb0160","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00406-016-0740-3","article-title":"Rates and predictors of relapse in first-episode non-affective psychosis: a 3-year longitudinal study in a specialized intervention program (PAFIP)","volume":"267","author":"Pelayo-Ter\u00e1n","year":"2017","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2020.03.009_bb0165","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.eurpsy.2018.03.003","article-title":"Duration of active psychosis and functional outcomes in first-episode non-affective psychosis","volume":"52","author":"Pelayo-Ter\u00e1n","year":"2018","journal-title":"European Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2020.03.009_bb0170","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1192\/bjp.bp.113.127753","article-title":"Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis","volume":"205","author":"Penttil\u00e4","year":"2014","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2020.03.009_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(99)00161-9","article-title":"Characterizing and dating the onset of symptoms in psychotic illness: the Symptom Onset in Schizophrenia (SOS) inventory","volume":"44","author":"Perkins","year":"2000","journal-title":"Schizophr. Res."},{"issue":"7","key":"10.1016\/j.schres.2020.03.009_bb5220","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1176\/appi.ajp.2015.14101329","article-title":"Early improvement as a predictor of later response to antipsychotics in schizophrenia: a diagnostic test review","volume":"172","author":"Samara","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2020.03.009_bb0185","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cpr.2017.09.007","article-title":"Predictors of functional recovery in first-episode psychosis: a systematic review and meta-analysis of longitudinal studies","volume":"58","author":"Santesteban-Echarri","year":"2017","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.schres.2020.03.009_bb6500","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.psychres.2017.04.050","article-title":"Early clinical recovery in first-episode psychosis: symptomatic remission and its correlates at 1-year follow-up","volume":"254","author":"Simonsen","year":"2017","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.schres.2020.03.009_bb0195","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/oxfordjournals.schbul.a033315","article-title":"Natural course of schizophrenic disorders: a 15-year follow-up of a Dutch incidence cohort","volume":"24","author":"Wiersma","year":"1998","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2020.03.009_bb0200","series-title":"WHO Psychiatric Disability Assessment Schedule","author":"World Health Organization","year":"1988"},{"issue":"2","key":"10.1016\/j.schres.2020.03.009_bb0205","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/schbul\/17.2.325","article-title":"Neuroleptics and the natural course of schizophrenia","volume":"17","author":"Wyatt","year":"1991","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2020.03.009_bb0210","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"issue":"2\u20133","key":"10.1016\/j.schres.2020.03.009_bb0215","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.schres.2013.08.001","article-title":"Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review","volume":"152","author":"Zipursky","year":"2014","journal-title":"Schizophr. Res."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996420301122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996420301122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:35:17Z","timestamp":1760297717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996420301122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":44,"alternative-id":["S0920996420301122"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2020.03.009","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Duration of active psychosis during early phases of the illness and functional outcome: The PAFIP 10-year follow-up study","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2020.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}